Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2005
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130956 1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130314 Diaminofluorescein derivatives
06/16/2005US20050129610 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor
06/16/2005US20050127336 Pyrano-quinolines, pyrano-quinolinones, combinations thereof, photochromic compositions and articles
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity
06/15/2005EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
06/15/2005EP1540382A1 Plastic photochromic lens and method for preparation thereof
06/15/2005EP1539767A2 Opiate analogs selective for the delta-opioid receptor
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539762A2 Bicyclic pyrimidinones as coagulation cascade inhibitors
06/15/2005EP1539761A1 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
06/15/2005EP1539740A1 Sulphonamide derivatives and their use as tace inhibitors
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539179A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
06/15/2005EP1539133A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
06/15/2005EP1419163B1 Tricyclic imidazopyridines
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1048658B1 Alicyclic acylated heterocyclic derivatives
06/15/2005EP1028963B1 Novel substituted phenyl keto enols
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626535A Ramification of chirality multi ring quinoline tetroxide, preparation method and usage
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1206535C Modulating multiple lineage kinase proteins
06/15/2005CN1206218C Aryl phenyl substituted cyclic ketoenols
06/14/2005US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials
06/14/2005US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
06/14/2005CA2150229C Nitric esters having a pharmacological activity and process for their preparation
06/09/2005WO2005051949A1 Novel condensed imidazole derivative
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051386A1 Hmg-coa reductase inhibitors and method
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005033112A3 Substituted indole derivatives
06/09/2005WO2005028475A3 Compositions useful as inhibitors of protein kinases
06/09/2005WO2005020914A3 Pyridomorphinans, pyridazinomorphinans and use thereof
06/09/2005WO2005013903A3 Derivatives of substituted quinone and uses thereof
06/09/2005WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma
06/09/2005US20050124646 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124638 Benzimidazoles and analogs thereof as antivirals
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005DE10351646A1 2-Halogen-6-alkyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-halo-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537123A1 Compounds
06/08/2005EP1537122A1 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
06/08/2005EP1537121A1 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
06/08/2005EP1537120A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
06/08/2005EP1537119A1 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1537089A2 Compounds compositions and methods
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1440075B1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005CN1625555A Quinazoline compounds
06/08/2005CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative
06/08/2005CN1623993A Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof
06/07/2005US6903110 Selective serotonin reuptake inhibitors
06/07/2005US6903109 Arylindenopyridines and related therapeutic and prophylactic methods
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/02/2005WO2005049735A2 A process for aqueous milling of quinacridone pigments
06/02/2005WO2005049621A1 5,6-dihydroxy-isoindole derivatives as linkers for oligomer solid phase synthesis
06/02/2005WO2005049620A1 Novel compounds
06/02/2005WO2005049619A1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof
06/02/2005WO2005049618A1 Manufacture of vitamin b6
06/02/2005WO2005049569A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
06/02/2005WO2005049019A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
06/02/2005WO2005048916A2 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
06/02/2005WO2005030332A3 Use of galanthamine and the derivatives thereof in the production of medicaments
06/02/2005WO2005009347A3 7-substituted camptothecin and camptothecin analogs and methods for preparing same
06/02/2005US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119228 Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
06/02/2005US20050119169 Spatially-defined macrocycles incorporating peptide bond surrogates
06/02/2005CA2546815A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
06/02/2005CA2546028A1 Novel compounds
06/02/2005CA2545491A1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof
06/01/2005EP1534716A1 Heterobicyclic pyrazole derivatives as kinase inhibitors
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 298